I assume lots of sales from recent HIV test rollout, covid and production increased will not be on the revenue of current FY report. But most of the upfront cost for ramping up production should be already factored in this report.
Next report should be even better on the revenue and profit margin increases.
Ann: FY20 Results Presentation, page-53
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.14M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 747274 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 416397 | 3 |
View Market Depth
| Last trade - 09.59am 18/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |
Day chart unavailable